Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and execution of clinical supply shipments of PEX010, a botanical psilocybin drug candidate developed by Filament Health Corp., to leading Canadian research institutions. Following its press release dated April 7, 2026, Red Light is highlighting recent accomplishments and ongoing momentum, including
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-24 8:26 AM EDT | Red Light Holland Corp.
Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), announces its financial results for the fourth quarter and year ended December 31, 2025. Q4 2025 HIGHLIGHTS Gross sales of $6.2 million, representing a 115% increase compared to $2.9 million in Q4 2024 Net revenue of $4.1 million (excluding excise
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-24 3:01 AM EDT | Herbal Dispatch Inc.
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector
Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, today highlights recent U.S. federal policy developments supporting psychedelic research and outlines the potential implications for the sector and the Company. Recent announcements by U.S. President Donald Trump include an exec
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-04-23 7:30 AM EDT | Psyched Wellness Ltd.
City View Green Holdings Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlements
Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that it proposes to undertake an up to $500,000 non-brokered private placement (the "Offering") of units (each, a "Unit") to be sold at a price of $0.05 per Unit. Each Unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to
Aliments / boissons, Cannabis, Extracteurs de cannabis, Producteurs de cannabis
2026-04-23 7:17 AM EDT | City View Green Holdings Inc.
Herbal Dispatch Welcomes the Honourable Herb Dhaliwal as Full-Time Chairman
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of the Honourable Herb Dhaliwal, PC, as a full-time Board Member and Chairman of the Board. The Honourable Herb Dhaliwal, brings a wealth of experience in public service, business, and leadership to Her
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-23 3:01 AM EDT | Herbal Dispatch Inc.
Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Delivra Health Brands Inc. (TSXV: DHB) OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that its wholly-owned subsidiary, LivCorp Inc., has entered into a licence agreement ("Licence Agreement") with Peak Processing Solutions ("Peak") (ASX: PKP), to manufacture, distribute and sell infu
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-04-22 5:45 PM EDT | Delivra Health Brands Inc.
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced that further to its previous disclosure regarding the timing of its fourth quarter and full year 2025 financial results release and conference call, the Company now expects to release its financial results for the perio
Cannabis, Cultivateurs de cannabis, Dispensaires de cannabis, Producteurs de cannabis
2026-04-21 4:30 PM EDT | VEXT Science, Inc.
Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market Maker
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce that the Company's common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC"). DTC eligibility significantly enhances accessibility for U.S.-based investor
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-21 3:01 AM EDT | Herbal Dispatch Inc.
Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce it has been granted a Health Canada Micro-Processing Licence for its second site of operations, Nextleaf Distribution. The issuance of this licence marks a key milestone in the Company's capex-light expansion strategy stre
Biotechnologies, Pharmaceutique, Cannabis, Extracteurs de cannabis
2026-04-20 9:00 AM EDT | Nextleaf Solutions Ltd.
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of Washington Second psilocybin session showed meaningful improvements in anxiety, depression, and overall psychological outcomes, with effects lasting up to 24 weeks 69% of participants fell below clinical thresholds for anxiety and depression after second treatment Research builds on prior studies utilizing Filament's botanica
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-20 7:30 AM EDT | Red Light Holland Corp.
PharmaCielo Announces Intention to Issue Interest Shares
Ontario and Rionegro, Colombia--(Newsfile Corp. - April 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and food and medicinal grade cannabis extracts for the natural pharmaceuticals and consumer products market, PharmaCielo
Cannabis, Extracteurs de cannabis
2026-04-17 7:30 AM EDT | PharmaCielo Ltd.
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that Cardiol's President and Chief Executive Officer, David Elsley, will participate in a live interview on X with
Biotechnologies, Cannabis, Santé, Producteurs de cannabis
2026-04-14 7:27 AM EDT | Cardiol Therapeutics Inc.
CURED Nutrition Joins One Hemp, Strengthening Industry Alignment Ahead of Key Federal Legislative Deadline
Washington, D.C.--(Newsfile Corp. - April 13, 2026) - CURED Nutrition, a Colorado-based wellness brand formulating non-intoxicating, full-spectrum cannabinoid supplements, today announced it has joined ONE HEMP, a national industry coalition advancing quality standards, transparency, and responsible federal regulation across the hemp CBD marketplace. The announcement comes as the industry approache
2026-04-13 7:55 AM EDT | OneHemp
Body and Mind Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Body and Mind Inc. (CSE: BAMM) (the "Company" or "BaM") is pleased to announce that it has closed the Illinois dispensary transactions, which it had previously disclosed in a news release dated January 30, 2025. NMG IL 4 Transaction: DEP Nevada, Inc. received $833,333 in cash less $43,831.56 for certain indebtedness of NMG IL 4 immediately prior to closing and transaction expenses. The transaction also
2026-04-10 11:38 AM EDT | Body and Mind Inc.
Stock Trend Capital Provides Younet AI Investment Update
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Stock Trend Capital Inc. (CSE: STCQ) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend"), is pleased to provide shareholders with an update regarding its investment in Younet AI ("Younet"). In connection with this update, the Company is providing Younet's most recent news release, reproduced in full below. Younet AI Partners with Perpetuals.com to L
Technologies, Technologies de l’Internet, Cannabis
2026-04-10 7:30 AM EDT | Stock Trend Capital Inc.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company's common shares effective April 13, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on March 23, 2026 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-04-09 8:30 AM EDT | Akanda Corp
FloraWorks Announces TruCBN(TM) Readiness for the CMS Substance Access BEI Program with Full Clinical and Safety Substantiation
Portland, Oregon--(Newsfile Corp. - April 9, 2026) - FloraWorks today announced that TruCBN™ 50 mg softgels are available to healthcare organizations evaluating sleep-focused hemp products for the CMS Substance Access Beneficiary Engagement Incentive (BEI) program. In a published 1,020-person randomized, double-blind, placebo-controlled clinical trial, TruCBN™ 50 mg dose demonstrated statistically significant improvement in sleep quality. Real-world evidence has
Technologies, Cannabis, Santé, Producteurs de cannabis
2026-04-09 8:00 AM EDT | FloraWorks
Digicann Ventures Announces Resignation of Director
Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that Jordan Fogle has resigned from the Board of Directors, effective immediately. Mr. Fogle has indicated that his current professional obligations require his full attention, which preclude him from continuing in his role as an independent director of the
Services bancaires / financiers, Cannabis
2026-04-08 5:30 PM EDT | Digicann Ventures Inc.
Akanda Adjourns Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that on March 31, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, April 27, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-04-07 8:30 AM EDT | Akanda Corp
Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that Filament Health Corp. ("Filament") signed three new license agreements and completed two research shipments during March 2026, further expanding the global cl
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-07 7:30 AM EDT | Red Light Holland Corp.